GAI

Global Antitrust Public Policy Conference on Global Antitrust Challenges for the Pharmaceutical Industry

Event Date: Tuesday, September 23, 2014

Location: J. W. Marriott Hotel, 1331 Pennsylvania Avenue, NW , Washington, DC 20004

Event Brochure

Program Description: The Global Antitrust Institute (GAI) at the Law & Economics Center at George Mason University School of Law is a leading international platform for research and education that focuses on the legal and economic analysis of key antitrust issues confronting competition agencies and courts around the world.

The GAI was founded in the belief that if policy-makers, officials, judges and other relevant stakeholders in charge of developing and applying antitrust law, also known as competition law, understand economics, they will be more likely to make decisions that promote consumer welfare and innovation.

On September 23, 2014 the GAI presented a conference on Global Antitrust Challenges for the Pharmaceutical Industry in Washington, DC. The conference featured panels focused on competition policy and life-cycle management strategies, antitrust and reverse patent settlements, antitrust in pharmaceutical markets when the government is the consumer, rebates and tying, and merger control in the pharmaceutical industry. These panels included some of the best known antitrust officials and practitioners working on pharmaceutical issues in North America and Europe. In addition, the conference highlights included a morning keynote address from Edith Ramirez, chairwoman of the US Federal Trade Commission and a lunch keynote address from John Pecman, Commissioner of Competition at the Competition Bureau Canada. 

*Available presentations are hyperlinked below. 

 

Agenda

Panel 1: Competition Policy and Life-Cycle Management Strategies

Chair
James M. Spears, Executive Vice President and General Counsel, The Pharmaceutical Research and Manufacturers of America (PhRMA)

Speakers
Michael A. Carrier, Distinguished Professor of Law, Rutgers University School of Law
Ingrid Vandenborre, Partner, Skadden Arps LLP

Panelists
Eric J. Stock, Antitrust Bureau Chief, Office of the Attorney General of New York
Ana Paula Martinez, Partner, Levy & Salomão Advogados
Heather M. Johnson, Attorney, Health Care Division, Federal Trade Commission

Presentations

 


 

Panel 2: Antitrust and Reverse Settlements: Unsettled Issues

Chair
Bruce H. Kobayashi, Professor of Law, George Mason University School of Law

Speakers
Markus H. Meier, Assistant Director, Health Care Division, Federal Trade Commission
Henri Piffaut, Head of Unit, Directorate General for Competition, European Commission

Panelists
Aaron Gal, Senior Research Analyst, Sanford C. Bernstein & Company
Sumanth Addanki, Senior Vice President, NERA Economic Consulting
Martha Starr, Associate Professor of Economics, American University

Presentations

 


 

Panel 3: Antitrust in Pharmaceutical Markets: When the Government is the Consumer

Chair
Jonathan B. Baker, Professor of Law, American University Washington College of Law

Speakers
Herbert J. Hovenkamp, Ben and Dorothy Willie Chair, University of Iowa College of Law
Gabriella Muscolo, Member of the Board, Italian Competition Authority

Panelists
Claudia Berg, Senior Director, Office for General Counsel, UK Competition and Markets Authority
Kees Hellingman, Senior Legal Officer, Authority for Consumers and Markets
John D. Graubert, Partner, Covington & Burling LLP

 




Panel 4: Rebates and Tying: Implications for Pharmaceutical Competition

Chair
The Honorable Douglas H. Ginsburg, Professor of Law, George Mason University School of Law and Senior Circuit Judge, US Court of Appeals for the District of Columbia Circuit

Speakers
Joshua D. Wright, Commissioner, Federal Trade Commission and Professor of Law, George Mason University School of Law (on leave)
Damien A. Geradin, Professor of Law, George Mason University School of Law and Partner, Covington & Burling LLP

Panelists
Abbott B. Lipsky, Jr., Partner, Latham & Watkins LLP
Hal J. Singer, Principal, Economists Incorporated
D. Daniel Sokol, Professor of Law, University of Florida Levin College of Law

Presentations

 


 

Panel 5: Merger Control in the Pharmaceutical Industry

Chair
Timothy J. Muris, George Mason University Foundation Professor of Law, George Mason University School of Law and Of Counsel, Kirkland & Ellis LLP

Speakers
Michael R. Moiseyev, Assistant Director, Mergers I, Bureau of Competition, Federal Trade Commission
Paul Csiszár, Director, Directorate General for Competition, European Commission

Panelists
Ilene K. Gotts, Partner, Wachtell Lipton Rosen & Katz
Monica Noether, Vice President, Charles River Associates
George S. Cary, Partner, Cleary Gottlieb Steen & Hamilton LLP

Presentations

 

*George Mason University School of Law is an approved provider of CLE in Virginia. Virginia MCLE credit was offered for those in attendance. Attorneys in other states received attendance forms to self-report in their state.

 **Hotel accommodations were NOT included in the registration fee. Room available at the conference rate and price were limited.

For More Information, Contact: Jeff Smith
Coordinator, Henry G. Manne Programs
703.993.8382
jsmithq@gmu.edu